NEOPLASIAS MIELOIDES Y LINFOIDES: DETECCIÓN DE TRANSLOCACIÓN t(8;9)(p22;p24) - gen PCM1::JAK2 - CIDEGEN
CIDEGEN
Delivery time
Resultados: <1 semana desde la recepción de la muestra.
Sample
Sangre (EDTA), Médula ósea (EDTA), Tejido parafinado (FFPE)
167,00€
Translocation occurring in both myeloid and lymphoid malignancies: CML-like chronic-phase disease with associated eosinophilia and bone marrow fibrosis, and possible progression to secondary AML and B-ALL. PCM1-JAK2-positive disease is aggressive compared with patients with the associated V617F JAK2 mutation. PCM1/JAK2 analysis.